COMP <GO>
NPKI vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
NPK International Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NPKI 7
— TMO 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NPKI
LAST: $11.20 (-0.88%) • MKT CAP: $951.0M
roic
10.30%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NPKI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NPKI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 10.30% | 9.30% | +1.00 | NPKI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.1x | 30.4x | -19.30 | NPKI | /valuation <GO> |
| Free Cash Flow Yield | 2.77% | 2.40% | +0.37 | NPKI | /fcf-yield <GO> |
| Operating Margin | 16.90% | 17.40% | -0.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 14.10% | 15.10% | -1.00 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 27.40% | 3.90% | +23.50 | NPKI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.02 | 4.50 | +2.52 | NPKI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | NPKI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 23.6 | 62.9 | -39.33 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.5x | 36.3x | -15.80 | NPKI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $951.0M | $262.22B | -$261.27B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NPKI REV | TMO REV | NPKI GROSS % | TMO GROSS % | NPKI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $277.0M | $44.56B | 36.4% | — | $26.3M | $6.29B |
| FY 2024 | $217.5M | $42.88B | 35.5% | — | -$5.4M | $7.27B |
| FY 2023 | $207.6M | $42.86B | — | — | $100.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NPKI // BETA —
TMO // BETA 0.94